BeyondBio
PrivateLast Round
Series E
May 1, 2026
Est. Valuation
$74.8M
Total Funding Raised
$41.64M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BeyondBio operates in Healthcare & Life Sciences and is based in Daejeon. Its latest recorded funding round was a Series E round in May 2026.
BeyondBio is a biotechnology company that develops therapeutic drugs and therapies for life-threatening diseases such as cancer and Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BeyondBio Comparables
Compare BeyondBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 1ST Biotherapeutics, Inc. | 86% | |
| SPARK Biopharma, Inc. | 84% | |
| Cureverse | 83% |
For institutional investors. Book with your work email.
BeyondBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | May 1, 2026 | ||||
| Series D | Sep 1, 2021 | ||||
| Series C | Apr 1, 2018 | ||||
| Series B | Jun 1, 2016 | ||||
| Series A | Jun 1, 2014 |
For institutional investors. Book with your work email.
BeyondBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ID Ventures | Series E |
| KB Investment | Series C |
| Tiger Asset Management | Series D |
| JX Partners | Series D |
| Brain Asset Management Co.,Ltd. | Series E |
| G.N.Tech Venture Capital | Series E |
| Dt& Investment | Series C, Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2026
$14M round with participation from Kolon Investment and ID Ventures.
- Sep 1, 2021
$14M round led by JX Partners and Tiger Asset Management.
For institutional investors. Book with your work email.
BeyondBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BeyondBio's valuation, stock price, and market status.
Is BeyondBio a public or private company?
BeyondBio is a private company.
What is the current stock price of BeyondBio?
BeyondBio is a private company, so its shares have no public market price. Caplight tracks BeyondBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BeyondBio worth (valuation)?
BeyondBio's valuation is estimated at $74.8M based on funding round data.
Can I buy BeyondBio stock?
BeyondBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BeyondBio's last funding round?
BeyondBio's most recent funding round was Series E on May 1, 2026.
Who are the main investors in BeyondBio?
Key investors in BeyondBio include ID Ventures, KB Investment, Tiger Asset Management, JX Partners, Brain Asset Management Co.,Ltd..
Will BeyondBio IPO soon?
No public IPO plans have been announced for BeyondBio.
How can I track BeyondBio secondary market activity?
Caplight tracks bids, offers, and trades in BeyondBio's shares on secondary markets.